Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
PHASE2
This phase II clinical trial tests a chemotherapy regimen (dose-adjusted et...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
PHASE2
This phase II trial tests how well etoposide, prednisone, vincristine, cycl...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium